Get started
Author

Yumeng Zhang

High-cholesterol-load-triggered pyroptosis of gingival fibroblasts promotes periodontitis
2026 · Zhenxiang Wang, Yueheng Li, et al. · International Immunopharmacology · 2
CD20×CD3 bispecific antibodies as bridging to CAR-T in aggressive B-cell lymphomas: a single-institution experience
2026 · Yumeng Zhang, Sameh Gaballa, et al. · Blood Immunology & Cellular Therapy
Patient characteristics, treatment patterns, and outcomes in primary CNS lymphoma of T-cell origin: A multi-institution retrospective analysis
2025 · Omar Elghawy, Nishwant Swami, et al. · Blood
Real-world efficacy outcomes of epcoritamab and glofitamab in Relapsed/Refractory aggressive B-cell lymphoma: A single-center cohort emphasizing trial-ineligible populations
2025 · Yumeng Zhang, Fatima Tuz Zahra, et al. · Blood
PDF
Clinical and genomic landscape of STAT5B mutations in lymphoid and myeloid malignancies
2025 · Fnu Amisha, Jessica Shostak, et al. · Blood
PDF
Effectiveness of epcoritamab in a heterogeneous population with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) including post-chimeric antigen receptor T-cell therapy (CAR T) patients: Insights from the real-world epcoritamab patient characteristics and outcomes research (Real-EPCOR) study
2025 · Amir Ali, Pallawi Torka, et al. · Blood
Outcomes of CD20xCD3 bispecific antibody therapy as holding or bridging therapy prior to chimeric antigen receptor T-cell infusion in aggressive B-cell lymphomas
2025 · Fatima Tuz Zahra, Yumeng Zhang, et al. · Blood
PDF
Impact of radiation in limited stage diffuse large B-cell lymphoma in the modern era
2025 · Juan Ramirez, Daniel DeAvila, et al. · Blood
Giant Cysticercosis of the Right Kidney: A Case Report
2024 · Yumeng Zhang, Huaqing Tan, et al. · Clinical Case Reports
PDF
Works count: 9
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type